Curing Corruption in China's Healthcare Industry - Risks and Opportunities

Upcoming Events

   

Breakfast Briefings

Curing Corruption in China's Healthcare Industry - Risks and Opportunities

The Chinese government has increased scrutiny of corruption in its vast healthcare system – and multinationals eager to do business in the world’s fastest growing healthcare market should watch carefully.  In addition, navigating the healthcare business landscape without falling foul of the provisions of the UK Bribery Act 2010 (UKBA) and the US Foreign Corrupt Practices Act 1977 (FCPA) should be a key consideration for companies linked to the UK and the US, since these legislations have extra-territorial application.

This briefing will be led by Brian Burke, a New York/Shanghai-based lawyer experienced in advising multinationals on corruption-related issues in the healthcare industry in Asia, and particularly China.  He will address the following topics:

- Key FCPA/UKBA enforcement risks in China’s healthcare industry

- Case Studies: Lessons from notable enforcement cases (including GSK, Novartis, Astra Zeneca, SciClone, and BMS)

- Observations on the latest kinds of employee and third-party misconduct

- How to promote compliance and mitigate enforcement risks
 

Fluent in Mandarin, Brian acted as lead advisor to GSK in its recent high profile case in China and has advised multiple other healthcare companies on compliance and investigations matters in China.

 

About the speaker

Brian Burke leads Shearman & Sterling's Asia Litigation Practice. He has conducted compliance investigations in every major jurisdiction in Asia. As a fluent Mandarin speaker, Brian has a particular focus on multinational consulting with operations in China. Brian acted as lead advisor to GlaxoSmithKline on the landmark bribery case against GSK in China, which is the first and only criminal bribery case to date against a foreign company in China. He currently divides his time between New York and Shanghai.  

 

This event is hosted by Andrew Seaton. 

Ticket includes a full hot English breakfast buffet.

Please note that Business Attire is required by the Hong Kong Club - collared shirts must be worn by men, and jeans, sandals and sports shoes are not permitted. To see the full list of club rules on dresscode, please click here.

ATTENDANCE FEE
ATTENDEE PRICE
Member $ 400.00 HKD
Non-Member $ 520.00 HKD
Y-Network $300.00 HKD
Startup $300.00 HKD
  • Reservations in advance are required. Please consider your booking confirmed unless notified otherwise.
  • Business Attire is required by the Hong Kong Club. No jeans or sports shoes.
  • Cancellations must be made in writing 24 hours prior to the event. No shows will be charged.
  • This event is closed to the media.
  • The event will be cancelled if the No.8 Typhoon signal or the Black Rain Storm warning is in force.
  • For further information please email yammie@britcham.com
  • Please make cheques payable to: "The British Chamber of Commerce in Hong Kong" & send it to Room 1201 Emperor Group Centre, 288 Hennessy Road, Hong Kong
Event:

Curing Corruption in China's Healthcare Industry - Risks and Opportunities

Date:
Wed, March 20, 2019
Time:
08:00 AM - 09:15 AM
Speaker:

Brian Burke, Partner, Shearman & Sterling, New York/Shanghai

Venue:
Victoria Suite, The Hong Kong Club, 1 Jackson Road, Central. Hosted by Andrew Seaton
Contact Person:
Yammie Yuen
Contact information:
yammie@britcham.com

KNOWLEDGE HUB